MenoCheck picoAMH ELISA by Ansh Labs

Manufacturer Ansh Labs  |   Model: AL-124  |  Available Worldwide
4.0
/
5.0
  |  1 reviews

The MenoCheck® picoAMH ELISA is FDA cleared for in vitro diagnostic use as an aid in the determination of menopausal status in women between 42 and 62 years of age. This is the only AMH test with the sensitivity to quantify declining AMH concentrations in women who are entering their menopausal transition.


MenoCheck picoAMH ELISA by Ansh Labs product image
picoAMH ELISA
Request Pricing

Receive your quote directly from the manufacturer.




Average Rating: 4.0
1 Scientist has reviewed this product

4 out of 5
Ease of use
4 out of 5
After sales service
4 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2019

  • Organization: Comilla Medical College Hospital



  • Ease of use
    4 out of 5
    After sales service
    4 out of 5
    Value for money
    4 out of 5
Nice kit.
Rating: 4.0

  • Application Area: Testing menupause

"It was easy to use. Price was reasonable."

Review date: 26 Jun 2019 | MenoCheck picoAMH ELISA

The Ansh Labs' MenoCheck picoAMH ELISA is a quantitative three-step sandwich immunoassay and is perfectly suited to the measurement of declining levels of AMH. The Ab pair was developed against specific linear epitopes on the associated dimers of AMH thus ensuring specificity and consistency of AMH detection, no detectable cross-reactivity to other isoforms of AMH, different conformations of AMH, or other TGF-Beta superfamily hormones.

  • Calibrators are rHum AMH
  • xhibits no interference by complement or heterophilic antibodies.
  • Analytical measurable range of 7.6 – 1,091 pg/mL.
  • Limit of quantitation is 3.2 pg/mL.
  • Total 4.5 hour incubation at room temperature.

Ansh Labs, located just south of Houston Texas, is an FDA registered manufacturer of diagnostic test kits, antibodies, antigens, and proteins.